|
ホンダ ゴロウ
Goro Honda
本田 五郎 所属 医学部 医学科（東京女子医科大学病院） 職種 教授・基幹分野長 |
|
| 論文種別 | 原著 |
| 言語種別 | 英語 |
| 査読の有無 | 査読なし |
| 表題 | Intrahepatic Cholangiocarcinoma With Neither Intrahepatic Metastasis Nor Lymph Node Metastasis Is the Optimal Indication for Hepatectomy With Adjuvant Therapy. |
| 掲載誌名 | 正式名：Cancer diagnosis & prognosis 略 称：Cancer Diagn Progn ISSNコード：27327787/27327787 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 2(2),pp.160-166 |
| 著者・共著者 | ARIIZUMI Shunichi†, YAMAMOTO Masakazu, KOTERA Yoshihito, HIGUCHI Ryota, YAMASHITA Shingo, KATO Takaaki, HIRATA YoYoshihiro, KATAGIRI SATOSHI, HONDA Goro, EGAWA Hiroto |
| 発行年月 | 2022/03 |
| 概要 | Background/Aim:The optimal indication of hepatectomy with adjuvant therapy for intrahepatic cholangiocarcinoma (ICC) has not been evaluated in detail.Patients and Methods:We retrospectively studied 224 patients with ICC who underwent hepatectomy between 2000 and 2019. Prognostic factors for overall survival (OS) were evaluated by univariate and multivariate analysis. A total of 127 patients were treated with adjuvant therapy (62 patients with chemotherapy and 65 patients with immunotherapy) after hepatectomy, and 97 patients were treated with hepatectomy alone.Results:Intrahepatic metastasis (IM), lymph node metastasis (LNM) of ICC, adjuvant chemotherapy, and adjuvant immunotherapy were significant prognostic factors for OS on multivariate analysis. In 127 patients with neither IM nor LNM, the 5-year OS rate was significantly higher in 36 patients with adjuvant chemotherapy (81%) and in 34 patients with adjuvant immunotherapy (68%) than in 57 patients with hepatectomy alone (45%).Conclusion:The absence of IM or LNM is the optimal indication for hepatectomy with adjuvant therapy in patients with ICC. |
| DOI | 10.21873/cdp.10090 |
| PMID | 35399165 |